Conditions: Acute Coronary Syndrome
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 2004
Healthy volunteers: no

Brief summary:
A multicenter, single arm, open label, Phase IV study to evaluate safety and to describe the incidence of major cardiovascular events of ticagrelor in Chinese patients with acute coronary syndrome

Detailed description:

Arms:
arm 1: 90 mg/tablet, 1 tablet bid

Interventions: intervention 1: Ticagrelor
Intervention descriptions: intervention 1: 90mg/tablet, 1 tablet bid

Protocol document: